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Supplemental material: A commentary on studies 
presenting projections of the future prevalence of dementia 
Literature search strategy and selection criteria 
The aim of the literature review was to identify articles published in peer-
reviewed journals presenting projections concerning the world as a whole or for 
individual continents. Relevant articles were identified from PubMed using the 
search ‘(alzheimer* or dementia) and (projection or forecast)’. Including only articles 
published in the last 10-years, written in English, and using adult humans aged 45+ 
resulted in 281 articles. Screening the title and abstract of these articles seventeen 
were selected for further inspection. Of these, two were excluded because they were 
either review articles or editorials, and a further two because they were not relevant 
(i.e. did not present projections). A further 8 were initially excluded as the 
projections concerned individual countries rather than continents. Of the remaining 
five studies, three presented projections for the entire world (1–3); four Europe (2–5); 
and two North America (2,3). For two studies estimates for certain regions could be 
combined to provide estimates for Latin America and the Caribbean, as well as Asia, 
Africa and Oceania (2,3).  
Since the studies concerning North America included only the US and Canada in 
their estimates, we also included three projections concerning the US alone (6–8). 
This was because, by this definition, 90% of the North American population lives in 
the US. 
Results 
Details of these studies are given in Table 1 and the number of cases of dementia 
or AD projected in Figure 1. Of the studies three extrapolated prevalence estimates 
to existing population and projections (1,2,4) and five employed cell based macro 
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simulations based on discrete time multi-state models for the incidence of dementia 
or Alzheimer’s disease (3,5–8). Two of the cell-based macro simulations additionally 
incorporated disease progression into the multi-state models (3,7). 
Irrespective of method or region, the projected number of cases of dementia was 
predicted to rise considerably during the first half of this century. Due to the larger 
expected gains in life expectancy for developing countries, steeper increases in the 
estimated number of cases of dementia in the regions consisting of Latin America 
and the Caribbean, and Africa, Asia and Oceania compared to Europe and North 
America (2,3). For example, Ferri et al. (2) estimated that between 2000 and 2040 
there would be a 229% increase in cases in Europe but a 534% increase in Latin 
America and the Caribbean. Moreover, the same study estimated that 59% of all 
cases of dementia would occur in Asia by 2050, compared to 48% in 2006. 
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Table 1. Details of studies identified in the literature search 
First author Year Condition Population Method Period Projection Prevalence/Incidence 
Input 
Mortality 
adjustment 
Progression 
Brookmeyer 1998 Alheimer's 
Disease 
US Macro 
simulation 
based on 
discrete time 
incidence 
model 
1997>2047 US census 
bureau 
population 
projection 
Incidence: Pooled 
estimates across 4 
US studies, 
modelled as 
exponential function 
(Bachman 1993; 
Herbert 1995; 
Kokmen 1988; 
Shock, 1984) 
RR = 1.44 (Evans, 
1991) 
na 
Sloane 2002 Alheimer's 
Disease 
US Macro 
simulation 
based on 
discrete time 
incidence-
progression 
model 
2000>2050 US census 
bureau 
population 
projection 
Prevalence: US 
General Accounting 
Office AD estimates, 
modelled as 
exponential function 
and calibrated to 
match GAO 
estimates 
Assumed 10% 
higher for mild and 
20% higher for 
mod/severe 
Average 4yr 
progression 
(Doody 2001), 
assume yearly 
probability is .28  
Wimo 2003 Dementia World Extraplotion 
of prevalence 
estimates 
1950>2050 UN 
population 
projection 
Prevalence: meta-
analysis estimates 
(Fratiglioni & Rocca, 
2001) 
na na 
Hebert 2003 Alheimer's 
Disease 
US Macro 
simulation 
based on 
discrete time 
incidence 
model 
2000>2050 US census 
bureau 
population 
projection 
Incidence: estimates 
from a Chicago 
based poputlation 
study (Evans 2003) 
RR = 1.44 (Evans, 
1991) 
na 
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Wancata 2003 Dementia; 
Alzheimer's 
Disease 
Europe Extraplotion 
of prevalence 
estimates 
2000>2051 UN 
population 
projection 
Prevalence: Pooled 
estimates across 
meta-analyses (Dem: 
Jorm 1987, Hofman 
1991, Lobo 2000, 
Ritchie & Kildea 
1995; AD: Rocca 
1991, My & Kellar 
2000, Lobo 2000) 
na na 
Ferri 2005 Dementia World; 
Europe; 
North 
America; 
Latin 
America & 
Carribean; 
Asia, Africa 
& Oceania 
Extraplotion 
of prevalence 
estimates 
2001>2040 UN 
population 
projection 
Prevalence: Delphi 
consensus estimates 
RR = 2.38 up to age 
89;  RR = 1.8 
women age 90+;  
RR = 1.6 males age 
90+ (EURODEM 
study: Jagger et al. 
2000) 
na 
Brookmeyer 2007 Alheimer's 
Disease 
World; 
Europe; 
North 
America; 
Latin 
America & 
Carribean; 
Asia, Africa 
& Oceania 
Macro 
simulation 
based on 
discrete time 
incidence-
progression 
model 
2006>2050 UN 
population 
projection 
Incidence: Estimates 
from meta-analysis 
(update Jorm & 
Jolley 1998) 
Excess mortality 
risk 11% (calibrated 
against 
Brookmeyer, 2002) 
Average 6-year 
progression 
(Neumann, 2001), 
assume yearly 
probability of .167  
Mura 2010 Dementia Europe Macro 
simulation 
based on 
discrete time 
incidence 
model 
2010>2050 Eurostat 
population 
projections 
Incidence: Estimates 
from meta-analysis 
(Frataglioni 2000,  
EURODEM review) 
Excess risk reduces 
with age: RR (65-
74y) = 3.75; RR (75-
84y) = 2.59; RR (85-
y+) = 1.59 (Ostbye 
1999) 
na 
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